A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 45,966 shares of PRCT stock, worth $4.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,966
Holding current value
$4.55 Million
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$45.73 - $69.19 $2.1 Million - $3.18 Million
45,966 New
45,966 $2.81 Million
Q1 2023

May 12, 2023

BUY
$26.64 - $39.74 $1.69 Million - $2.53 Million
63,566 New
63,566 $1.81 Million
Q1 2022

May 13, 2022

SELL
$16.89 - $35.74 $3.03 Million - $6.41 Million
-179,300 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$24.6 - $46.29 $4.41 Million - $8.3 Million
179,300 New
179,300 $4.48 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.42B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.